Global Digital Pathology Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 210 pages | ID: GA4AE8C5CA0EN
Precision Business Insights (PBI)

Abstracts

Global Digital Pathology Market:

Global digital pathology market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for digital pathology is projected to reach US$ XX Mn by 2023.

Digital pathology can be defined as image-based information for the analysis, management, and interpretation of information achieved from a digital slide. In the field of pathology digital pathology is emerging technology. In the modern technology, specimen samples containing slides are converted into digital images for easy view, storage, analysis, and management of data collected and this enables the virtual microscopy, technology that enables posting image and transmission throughout the network connected. Data rich image helps in maintenance of patient health records electronically, therefore helps to compile and distribute the information to build the central database.

The growth of digital pathology globally anticipated grow at significant rate owing to the cost-effective procedures, ease of slides transportation virtually, and high efficient analysis of digital slides. Images can processed by computing algorithms, and can produce enhanced output. Furthermore, the time required for the diagnosis also reduced significantly through digital pathology techniques. In addition, low chances of errors in observation as well as interpretation make it the digital pathology as most significant technology in the pathology. Therefore, digital pathology showing increased adaptation rates over the conventional pathology treatments. Based on aforementioned factors digital pathology market is expected to show significant growth rate over the forecast period. However, lack of skilled personnel and unfavourable reimbursement policies are factors that expected to hamper the market growth.

Digital Pathology Market segmented based on product, type, application, end user, and region.

Based on product, digital pathology market segmented as:

• Scanners
• Software
• Communication Systems
• Storage Systems

Based on type, digital pathology market is segmented as:

• Human Digital Pathology
• Animal Digital Pathology

Based on application, digital pathology market is segmented as:

• Tele consultation
• Disease Diagnosis
• Drug Discovery

Based on the end user, digital pathology market is segmented as:

• Hospitals
• Pharmaceutical companies
• Academic institutes

Digitalization of pathology led to the automation of the tests during diagnosis, thus saving cost and efforts. For example, now a single digital instrument can perform those tests that were previously performed using five instruments by pathologists. The net effect has been observed in the form of impressive cost-reduction in total cost of diagnostic procedures and services. Digitization of tissue slides offers pathologists ease in diagnosis and detection of disease and digitized tissue can be analyzed using computer algorithms. The advancements in digital pathology is expected to take the conventional pathology to a more advanced level. Digital pathology evolution contributed to faster and accurate detection and diagnosis of chronic diseases. Currently, market players adopting collaborations, product develepments and launches as key strategies. For instance, In 2016 Visiopharm, partenerd with Inter Instrument A and LRI Imaging, to deploy digital pathology systems in Scandinavia.

Geographically, digital pathology market segmented into five regions they are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to grow at significant rate in digital pathology market owing to technological advancements and increase in R&D investments. Europe is expected to be another major market for the digital pathology owing to presence of large number of patient pool. Asia Pacific is expected to grow at the significant growth rate owing to adaptation rates of digital imaging in emerging economies, rising investments to adopt new technologies and devices, and the presence of untapped opportunities.Asia Pacific market expected to hav lucrative market growth opportunity owing to increase in incidence of cancer and growing demand for novel treatment options, developing healthcare facilities, and low laboratory expenses.

Some of the major players in global digital pathology are Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.

In March 2017, Danaher Corporation partened with Leeds Hospital to improve productivity and workflow

In June 2016, Royal Philips, acquired PathXL, a pathology, image-based analysis firm to develop integrated tools targeting applications in computational biology, education, workflow solutions, and image analytics

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL DIGITAL PATHOLOGY MARKET INTRODUCTION

2.1. Global Digital Pathology Market– Taxonomy
2.2. Global Digital Pathology Market–Definitions
  2.2.1. Product Type
  2.2.2. Application

3. GLOBAL DIGITAL PATHOLOGY MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Digital Pathology Market Dynamics – Factors Impact Analysis
3.6. Global Digital Pathology Market– Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan

4. GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Scanners
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Software
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Communication Systems
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Storage Systems
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis

6. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Teleconsultation
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Disease Diagnosis
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Drug Discovery
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Human Digital Pathology
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Animal Digital Pathology
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis

8. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical companies
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Academic institutes
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis

9. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Type, By End User, and Region, 2017 – 2023

10. NORTH AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Scanners
    10.1.1.2. Software
    10.1.1.3. Communication Systems
    10.1.1.4. Storage Systems
  10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Teleconsultation
    10.1.2.2. Disease Diagnosis
    10.1.2.3. Drug Discovery
  10.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Human Digital Pathology
    10.1.3.2. Animal Digital Pathology
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Hospitals
    10.1.4.2. Pharmaceutical companies
    10.1.4.3. Academic institutes
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
  10.1.7. North America Digital Pathology Market Dynamics – Trends

11. EUROPE DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Scanners
    11.1.1.2. Software
    11.1.1.3. Communication Systems
    11.1.1.4. Storage Systems
  11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Teleconsultation
    11.1.2.2. Disease Diagnosis
    11.1.2.3. Drug Discovery
  11.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Human Digital Pathology
    11.1.3.2. Animal Digital Pathology
  11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Hospitals
    11.1.4.2. Pharmaceutical companies
    11.1.4.3. Academic institutes
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
  11.1.7. Europe Digital Pathology Market Dynamics – Trends

12. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Scanners
    12.1.1.2. Software
    12.1.1.3. Communication Systems
    12.1.1.4. Storage Systems
  12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Teleconsultation
    12.1.2.2. Disease Diagnosis
    12.1.2.3. Drug Discovery
  12.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Human Digital Pathology
    12.1.3.2. Animal Digital Pathology
  12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Hospitals
    12.1.4.2. Pharmaceutical companies
    12.1.4.3. Academic institutes
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Digital Pathology Market Dynamics – Trends

13. LATIN AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Scanners
    13.1.1.2. Software
    13.1.1.3. Communication Systems
    13.1.1.4. Storage Systems
  13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Teleconsultation
    13.1.2.2. Disease Diagnosis
    13.1.2.3. Drug Discovery
  13.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Human Digital Pathology
    13.1.3.2. Animal Digital Pathology
  13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Hospitals
    13.1.4.2. Pharmaceutical Companies
    13.1.4.3. Academic Institutes
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
  13.1.7. Latin America Digital Pathology Market Dynamics – Trends

14. MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.1.1. Scanners
    14.1.1.2. Software
    14.1.1.3. Communication Systems
    14.1.1.4. Storage Systems
  14.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Teleconsultation
    14.1.2.2. Disease Diagnosis
    14.1.2.3. Drug Discovery
  14.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Human Digital Pathology
    14.1.3.2. Animal Digital Pathology
  14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Hospitals
    14.1.4.2. Pharmaceutical companies
    14.1.4.3. Academic institutes
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
  14.1.7. MEA Digital Pathology Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Perkin Elmer, Inc. (U.S.)
  15.2.2. Olympus Corporation (Japan)
  15.2.3. Sectra AB (Sweeden)
  15.2.4. GE Healthcare (U.K.)
  15.2.5. Inspirata Co. (U.S.)
  15.2.6. The Danaher Corporation (U.S.)
  15.2.7. Koninklijke Philips N.V (Netherlands)
  15.2.8. F. Hoffmann-La Roche AG (Switzerland)
  15.2.9. Digipath Co. (U.S.)
  15.2.10. Carl Zeiss AG (Germany)
  15.2.11. 3D-Histech Ltd. (Hungary)
  15.2.12. Yokogawa Electronic Corporation (Japan)
  15.2.13. Quorum Technologies Inc. (Canada)
  15.2.14. Hamamatsu Photonics K.K. (Japan)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS